Palatin Technologies (PTN) Set to Announce Quarterly Earnings on Friday

Palatin Technologies (NYSEAMERICAN:PTN) is expected to release its Q1 2027 results before the market opens on Friday, November 13th. Analysts expect the company to announce earnings of ($0.42) per share and revenue of $2.51 million for the quarter. Parties can check the company’s upcoming Q1 2027 earnings report page for the latest details on the call scheduled for Thursday, November 19, 2026 at 11:00 AM ET.

Palatin Technologies (NYSEAMERICAN:PTN) last announced its quarterly earnings data on Monday, September 28th. The company reported ($1.11) earnings per share for the quarter, topping the consensus estimate of ($1.20) by $0.09. The firm had revenue of $0.30 million for the quarter, compared to analyst estimates of $1.50 million.

Palatin Technologies Price Performance

Shares of Palatin Technologies stock opened at $6.27 on Monday. Palatin Technologies has a 52-week low of $4.51 and a 52-week high of $31.00. The company’s fifty day moving average price is $8.69 and its two-hundred day moving average price is $13.73.

About Palatin Technologies

Palatin Technologies, Inc is a biopharmaceutical company focused on developing medicines that target melanocortin receptors, a group of receptors involved in regulating inflammation, immune responses, metabolism and sexual function. The company’s research programs are designed to address conditions for which targeted therapies may offer an alternative to existing treatments.

Palatin’s most recognized product is Vyleesi (bremelanotide), a melanocortin receptor agonist approved by the U.S.